|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/51 | |
| A61P 35/00 |
| (11) | Patento numeris | 3344253 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16774460.6 |
| Europos patento paraiškos padavimo data | 2016-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/070893 |
| Data | 2016-09-05 |
| (87) | Numeris | WO 2017/037300 |
| Data | 2017-03-09 |
| (30) | Numeris | Data | Šalis |
| 201515716 | 2015-09-04 | GB | |
| 201515712 | 2015-09-04 | GB | |
| 201515714 | 2015-09-04 | GB | |
| 201515718 | 2015-09-04 | GB | |
| 201562217346 P | 2015-09-11 | US | |
| 201562217332 P | 2015-09-11 | US | |
| 201605583 | 2016-04-01 | GB | |
| 201608660 | 2016-05-17 | GB |
| (72) |
LINDMARK, Bertil, SG
OOI, Lisa, SG
|
| (73) |
Aslan Pharmaceuticals PTE Limited,
83 Clemenceau Avenue 12-03 UE Square, Singapore 239920,
SG
|
| (54) | VARLITINIB FOR USE IN THE TREATMENT OF RESISTANT OR REFRACTORY CANCER |
| VARLITINIB FOR USE IN THE TREATMENT OF RESISTANT OR REFRACTORY CANCER |